Skip to content
Health Canada authorized the first tests in humans of the company’s vaccine against Bundibugyo virus disease, the cause of the ongoing Ebola outbreak, the largest ever in the Democratic Republic of the Congo. Phase 1 clinical trials test pharmaceuticals in healthy people, mainly to look for unexpected side effects and harms. Moderna said Tuesday it has already begun the trial. (The Logic)
Talking point: Another potential Bundibugyo vaccine is in trials in the United Kingdom but Moderna’s is the first using the mRNA technology that proved itself against COVID-19. The Public Health Agency of Canada works with Moderna on mRNA vaccines and drugs, to support production at the company’s factory near Montreal. The arrangement is particularly important to the company given the Trump administration’s skepticism toward mRNA technology; although Moderna has huge financial reserves thanks to its COVID-19 vaccine and numerous potential products in its pipeline, it lost about US$800 million in its most recent quarter.
Loading...
Thanks for sharing!
You have shared 5 articles this month and reached the maximum amount of shares available.
CloseThis account has reached its share limit.
If you would like to purchase a sharing license please contact The Logic support at [email protected].
CloseGift the full article!
You have gifted 0 article(s) this month and have 5 remaining.
Recipients will be able to read the full text of the article after submitting their email address. They will not have access to other articles or subscriber benefits.
Most Popular This Week
In-depth, agenda-setting reporting
Great journalism delivered straight to your inbox.
News
‘Lego’ homes or housing solution? Canadians are split on modular housing
Briefing
Dominion Dynamics is pitching to take over an idled Stellantis plant
Three Canadian cities crack top 10 list of North American tech hubs
Moderna and Merck report promising trial results for mRNA-based melanoma vaccine
Best business newsletter in Canada
Get up to speed in minutes with insights and analysis on the most important stories of the day, every weekday.
Exclusive events
See the bigger picture with reporters and industry experts in subscriber-exclusive events.
Membership in The Logic Council
Membership provides access to our popular Slack channel, participation in subscriber surveys and invitations to exclusive events with our journalists and special guests.
